Search
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
Minglr: New open source software supports impromptu conversations
By
‘Those ad-hoc interactions are what people miss in today’s work-from-home environment.’
Pandemic Response CoLab: New initiative to solve COVID-19 challenges
By
The initiative is open to individuals, businesses and groups with the goal of developing a diverse, global community of problem solvers.
Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
Finance at MIT Ecosystem
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
MIT LFE and Informa Pharma Intelligence launch Project ALPHA
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
JuMP achieves a new milestone in the open source community
By
The designation increases JuMP’s visibility and status, and helps it attract funding
A generative AI tool to inspire creative workers
By
Generative artificial intelligence can help designers come up with new ideas, according to a new study.